Skip to main content
Clinical Trials/RPCEC00000440
RPCEC00000440
Not yet recruiting
未知

Study of the efficacy, safety and tolerability of soft capsules with ozonated sunflower oil versus oral OLEOZON® in patients with Giardiosis - AGO-GIA

ational Centre for Scientific Research (CNIC)0 sites200 target enrollmentMay 9, 2024
ConditionsGiardiosis

Overview

Phase
未知
Intervention
Not specified
Conditions
Giardiosis
Sponsor
ational Centre for Scientific Research (CNIC)
Enrollment
200
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 9, 2024
End Date
December 27, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
ational Centre for Scientific Research (CNIC)

Eligibility Criteria

Inclusion Criteria

  • Patients of both sexes, with 19 years or older, with gastrointestinal symptoms as diarrhea, pain in the upper abdomen, nausea, vomiting, weight loss, bloating or hivesand, a confirmatory diagnosis of Giardiosis who attend an outpatient clinic at the Institute of Gastroenterology and agree to participate in the study, written informed consent.

Exclusion Criteria

  • Patients with:
  • 1\. Other parasites
  • 3\. Decompensated chronic diseases
  • 4\. Diagnosed neoplasms
  • 5\. Pregnant or lactating women
  • 6\. Hypersensitivity to the study drug

Outcomes

Primary Outcomes

Not specified

Similar Trials